PLC Systems Inc. (PLCSF) Prepares to Begin Trials of RenalGuard
PLC Systems Inc. is a medical device company focused on innovative technologies for the cardiac and vascular markets. The company's newest product, RenalGuard, has been developed to help prevent the onset of Contrast-Induced Nephropathy (CIN) in at-risk patients undergoing certain imaging procedures. The company today announced that it is preparing to start the pivotal trial in the US for RenalGuard as it seeks approval for sales and marketing in the United States from the Food and Drug Administration. RenalGuard has already obtained CE Mark approval in the European Union. The RenalGuard system consists of a patented closed loop, software-controlled console…